NIH-funded research U01 cooperative agreement

mChoice: Boosting PrEP Use and Adherence for Black and Latino MSM with Tailored Training and Support

Official title: mChoice: Improving PrEP Uptake and Adherence among Minority MSM through Tailored Provider Training and Adherence Assistance in Two High Priority Settings

Funded at Columbia University Health Sciences · NIH-11624204 · Data updated 2026-11-12

A national study to help Black and Latino men who have sex with men start and stick with PrEP through culturally matched provider training and patient support.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2021
Project endSeptember 29, 2027
Funding year2025
Award (this year)$1,499,999
NIH project number6U01PS005229-05M001
Project IDNIH-11624204 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are young Black/African American and Hispanic/Latino MSM at risk for HIV who are considering or currently using PrEP, and their healthcare providers in the two high-priority settings.

Less likely to help

Patients not using PrEP or not at risk of HIV infection may not benefit from this study.

What this research studies

This project partners with clinics to train providers on PrEP screening, counseling, and initiation that fit the needs of young Black and Latino MSM. It also develops adherence support to help patients start PrEP and stay on it, using strategies tailored to this population. The study will compare practical approaches in two high-priority settings to see which methods most effectively increase PrEP uptake and persistence. Researchers will engage communities to ensure materials and messages are culturally congruent and accessible. The effort aims to reduce new HIV infections in communities with the highest risk.

Why it matters

Potential benefit: If successful, patients could gain easier access to PrEP and better adherence, lowering HIV risk in high-priority groups.

How similar studies have gone: Previous work has shown that targeted provider training and adherence support can improve PrEP uptake and persistence in high-risk populations.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Schnall, Rebecca — Columbia University Health Sciences
  • Study coordinator: Schnall, Rebecca

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.